| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |